| Title : Rituximab in Myasthenia Gravis- Experience from a Low- and Middle-Income Country (LMIC) Setting - Shivaram_2022_Neurol.India_70_1931 |
| Author(s) : Shivaram S , Nagappa M , Varghese N , Seshagiri DV , Duble S , Siddappa SA , Hesarur N , Sinha S , Taly AB |
| Ref : Neurol India , 70 :1931 , 2022 |
| Abstract : |
| PubMedSearch : Shivaram_2022_Neurol.India_70_1931 |
| PubMedID: 36352590 |
| Title : Rituximab in Myasthenia Gravis- Experience from a Low- and Middle-Income Country (LMIC) Setting - Shivaram_2022_Neurol.India_70_1931 |
| Author(s) : Shivaram S , Nagappa M , Varghese N , Seshagiri DV , Duble S , Siddappa SA , Hesarur N , Sinha S , Taly AB |
| Ref : Neurol India , 70 :1931 , 2022 |
| Abstract : |
| PubMedSearch : Shivaram_2022_Neurol.India_70_1931 |
| PubMedID: 36352590 |
| Title : Rituximab in Myasthenia Gravis- Experience from a Low- and Middle-Income Country (LMIC) Setting - Shivaram_2022_Neurol.India_70_1931 |
| Author(s) : Shivaram S , Nagappa M , Varghese N , Seshagiri DV , Duble S , Siddappa SA , Hesarur N , Sinha S , Taly AB |
| Ref : Neurol India , 70 :1931 , 2022 |
| Abstract : |
| PubMedSearch : Shivaram_2022_Neurol.India_70_1931 |
| PubMedID: 36352590 |